Expanding the Scope of Precision Care for Patients With HR-Positive Breast Cancers: Things You Should Know

Download All
Learn from expert faculty as they discuss application of recent clinical evidence to develop personalized treatment plans for HR-positive/HER2-negative early and advanced breast cancer, the use of current and emerging oral targeted therapies and strategies to promote adherence with a downloadable slideset from a satellite symposium, an on-demand webcast, and expert commentary.
Komal Jhaveri, MD
Program Director
Erica Mayer, MD, MPH
Laura M. Spring, MD

Downloadable Slidesets

Download these slides from an expert-led symposium reviewing the latest advances in targeted therapy for HR-positive/HER2-negative early-stage breast cancer.

Komal Jhaveri, MD
Program Director
Erica Mayer, MD, MPH
Released: June 6, 2022

Download these slides from an expert-led symposium for the most recent data on the selection and sequencing of targeted therapy for HR-positive/HER2-negative metastatic breast cancer.

Komal Jhaveri, MD
Program Director
Released: June 7, 2022

Download these slides from an expert-led symposium on the practical management of adverse events with targeted therapy for HR-positive/HER2-negative breast cancer and strategies to optimize adherence.

Komal Jhaveri, MD
Program Director
Laura M. Spring, MD
Released: June 6, 2022

On-Demand Webcast

In this on-demand webcast from a live symposium, experts Komal Jhaveri, MD, FACP; Erica L. Mayer, MD, MPH; and Laura M. Spring, MD, discuss how they apply current clinical evidence to develop personalized treatment plans for HR-positive/HER2-negative early and advanced breast cancer, including the use of current and emerging targeted therapies and strategies to promote patient adherence.

Komal Jhaveri, MD
Program Director
Erica Mayer, MD, MPH Laura M. Spring, MD
Physicians: maximum of 1.5 AMA PRA Category 1 Credits Released: June 10, 2022 Expired: June 9, 2023
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Lilly
Novartis Pharmaceuticals Corporation
Sanofi Genzyme

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings